Swigris JJ - Search Results

1

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.

King TE Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L, Lederer DJ, Nathan SD, Pereira CA, Sahn SA, Sussman R, Swigris JJ, Noble PW; ASCEND Study Group. King TE Jr, et al. Among authors: swigris jj. N Engl J Med. 2014 May 29;370(22):2083-92. doi: 10.1056/NEJMoa1402582. Epub 2014 May 18. N Engl J Med. 2014. PMID: 24836312 Free article. Clinical Trial.

2

Acute interstitial pneumonia and acute exacerbations of idiopathic pulmonary fibrosis.

Swigris JJ, Brown KK. Swigris JJ, et al. Semin Respir Crit Care Med. 2006 Dec;27(6):659-67. doi: 10.1055/s-2006-957337. Semin Respir Crit Care Med. 2006. PMID: 17195142 Review.

3

Quality of life and dyspnoea in patients treated with bosentan for idiopathic pulmonary fibrosis (BUILD-1).

Raghu G, King TE Jr, Behr J, Brown KK, du Bois RM, Leconte I, Roux S, Swigris J. Raghu G, et al. Eur Respir J. 2010 Jan;35(1):118-23. doi: 10.1183/09031936.00188108. Epub 2009 Aug 13. Eur Respir J. 2010. PMID: 19679600 Free PMC article. Clinical Trial.

4

The SF-36 and SGRQ: validity and first look at minimum important differences in IPF.

Swigris JJ, Brown KK, Behr J, du Bois RM, King TE, Raghu G, Wamboldt FS. Swigris JJ, et al. Respir Med. 2010 Feb;104(2):296-304. doi: 10.1016/j.rmed.2009.09.006. Epub 2009 Oct 7. Respir Med. 2010. PMID: 19815403 Free PMC article.

5

The 6 minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important difference.

Swigris JJ, Wamboldt FS, Behr J, du Bois RM, King TE, Raghu G, Brown KK. Swigris JJ, et al. Thorax. 2010 Feb;65(2):173-7. doi: 10.1136/thx.2009.113498. Epub 2009 Dec 8. Thorax. 2010. PMID: 19996335 Free PMC article. Clinical Trial.

6

Heart rate recovery after six-minute walk test predicts pulmonary hypertension in patients with idiopathic pulmonary fibrosis.

Swigris JJ, Olson AL, Shlobin OA, Ahmad S, Brown KK, Nathan SD. Swigris JJ, et al. Respirology. 2011 Apr;16(3):439-45. doi: 10.1111/j.1440-1843.2010.01877.x. Respirology. 2011. PMID: 20946337 Free PMC article.

7

Efficacy and safety of sirolimus in lymphangioleiomyomatosis.

McCormack FX, Inoue Y, Moss J, Singer LG, Strange C, Nakata K, Barker AF, Chapman JT, Brantly ML, Stocks JM, Brown KK, Lynch JP 3rd, Goldberg HJ, Young LR, Kinder BW, Downey GP, Sullivan EJ, Colby TV, McKay RT, Cohen MM, Korbee L, Taveira-DaSilva AM, Lee HS, Krischer JP, Trapnell BC; National Institutes of Health Rare Lung Diseases Consortium; MILES Trial Group. McCormack FX, et al. N Engl J Med. 2011 Apr 28;364(17):1595-606. doi: 10.1056/NEJMoa1100391. Epub 2011 Mar 16. N Engl J Med. 2011. PMID: 21410393 Free PMC article. Clinical Trial.

8

Clinical trials and tribulations--lessons from pulmonary fibrosis.

Olson AL, Swigris JJ, Brown KK. Olson AL, et al. Among authors: swigris jj. QJM. 2012 Nov;105(11):1043-7. doi: 10.1093/qjmed/hcs066. Epub 2012 May 29. QJM. 2012. PMID: 22647760 Free PMC article.

9

The UCSD shortness of breath questionnaire has longitudinal construct validity in idiopathic pulmonary fibrosis.

Swigris JJ, Han M, Vij R, Noth I, Eisenstein EL, Anstrom KJ, Brown KK, Fairclough D. Swigris JJ, et al. Respir Med. 2012 Oct;106(10):1447-55. doi: 10.1016/j.rmed.2012.06.018. Epub 2012 Jul 15. Respir Med. 2012. PMID: 22801586 Free PMC article.

10

Health-related quality of life in idiopathic pulmonary fibrosis: where are we now?

Belkin A, Swigris JJ. Belkin A, et al. Among authors: swigris jj. Curr Opin Pulm Med. 2013 Sep;19(5):474-9. doi: 10.1097/MCP.0b013e328363f479. Curr Opin Pulm Med. 2013. PMID: 23851327 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

201 results

Search Page